Internal Medicine, Pulmonary Disease · Mayaguez, PR
NPI
1811978018
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Cpr Professional Building, 55 Calle de Diego Este Suite 401
Mayaguez, PR, 00680
Phone (787) 832-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
191 services
Medicare patients, 2024
66
Average age 76
Drug cost, 2024
$2.1M
5,312 prescriptions
Company payments, 2025
$686
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Antonio M Padua-Ramos was code 99213 (office e&m - established), 58 times for 36 patients. In total Antonio M Padua-Ramos billed 191 services in 14 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 58 | 36 | $56.37 | $3,269 |
| 94375 Pulmonary Function Testing | Office | 29 | 25 | $26.88 | $780 |
| 99203 Office E&M - New | Office | 18 | 18 | $69.75 | $1,255 |
| 94729 Pulmonary Function Testing | Office | 12 | 12 | $35.28 | $423 |
By year: 2022 $21K for 210 services; 2023 $17K for 194 services; 2024 $16K for 191 services.
Medicare prescription drug claims, 2024
In 2024, the drug Antonio M Padua-Ramos prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,023 prescriptions and refills. In total Antonio M Padua-Ramos wrote 5,312 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,023 | 1,026 | 247 | $48K |
| Montelukast Sodium Generic | 532 | 576 | 158 | $3,881 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 451 | 463 | 125 | $130K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 236 | 238 | 74 | $59K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 222 | 224 | 52 | $109K |
| Fluticasone Propionate Generic | 221 | 234 | 90 | $3,168 |
| Albuterol Sulfate Generic | 157 | 157 | 61 | $3,174 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 139 | 141 | 26 | $93K |
| Famotidine Generic | 136 | 142 | 73 | $766 |
| Chlorthalidone Generic | 125 | 128 | 50 | $1,101 |
| Pantoprazole Sodium Generic | 123 | 127 | 60 | $780 |
| Dexamethasone Generic | 118 | 118 | 58 | $1,277 |
| Levofloxacin Generic | 107 | 107 | 83 | $885 |
| Symbicort Budesonide/Formoterol Fumarate | 84 | 88 | 39 | $21K |
| Breo Ellipta Fluticasone/Vilanterol | 81 | 81 | 13 | $33K |
Brand drugs: 2,455 claims; generic drugs: 2,857 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antonio M Padua-Ramos $686 ($686 in general payments such as food, travel and fees) from 5 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $344.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.